Primary outcomes included serum anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), antral follicle count (AFC), and pregnancy rates.<h4>Results</h4>This meta-analysis included seven RCTs involving 422 women with poor ovarian reserve or ovarian insufficiency/failure. This evidence concerns the gene BRD2 and ovarian dysfunction.